Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in TaxesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Cash from Investing Activities (2022 - 2025)

Historic Cash from Investing Activities for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to $3.0 million.

  • InflaRx's Cash from Investing Activities fell 8413.3% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.5 million, marking a year-over-year decrease of 10774.21%. This contributed to the annual value of $56.7 million for FY2024, which is 39766.0% up from last year.
  • According to the latest figures from Q3 2025, InflaRx's Cash from Investing Activities is $3.0 million, which was down 8413.3% from -$28.2 million recorded in Q2 2025.
  • Over the past 5 years, InflaRx's Cash from Investing Activities peaked at $29.7 million during Q1 2022, and registered a low of -$28.2 million during Q2 2025.
  • In the last 4 years, InflaRx's Cash from Investing Activities had a median value of $3.0 million in 2025 and averaged $3.5 million.
  • In the last 5 years, InflaRx's Cash from Investing Activities soared by 86043.99% in 2024 and then plummeted by 53677.59% in 2025.
  • Quarter analysis of 4 years shows InflaRx's Cash from Investing Activities stood at $1.8 million in 2022, then skyrocketed by 64.91% to $3.0 million in 2023, then plummeted by 31.24% to $2.1 million in 2024, then skyrocketed by 45.61% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, -$28.2 million for Q2 2025, and $18.6 million during Q1 2025.